Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease

Kinoshita, H., Mandava, M., Jensen-Wachspress, M., Lang, H., Joy, E., Tanna, J., McCann, C. D., O’Brien, S., Burnett, S., Shibli, A., Hoq, F., Bhatia, M., Hanley, P. J., Dávila Saldaña, B., Mahadeo, K. M., Bollard, C. M., Keller, M. D., & Abraham, A. (2023). Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease. Blood Advances, 7(10), 2105–2116. https://doi.org/10.1182/bloodadvances.2022008219
Authors:
Hannah Kinoshita
Mamatha Mandava
Mariah Jensen-Wachspress
Hua Liang
Elisabeth Joy
Jay Tanna
Chase D. McCann
Samuel C. O’Brien
Sianna Burnett
Abeer Shibli
Fahmida Hoq
Monica Bhatia
Patrick J. Hanley
Blachy J. Dávila Saldaña
Kris M. Mahadeo
Catherine M. Bollard
Michael D. Keller
Allistair Abraham
Affiliated Authors:
Monica Bhatia
Columbia Affiliation:
Subjects:
Epstein-Barr Virus Infections (MeSH)
Virus Diseases (MeSH)
Graft vs Host Disease (MeSH)
Hematopoietic Stem Cell Transplantation (MeSH)
Anemia, Sickle Cell (MeSH)
Parvovirus B19 Infection and Pathogenesis (OpenAlex Topic)
Epidemiology and Management of Cytomegalovirus Infection (OpenAlex Topic)
Polyomavirus-Associated Carcinogenesis and Clinical Manifestations (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2022008219
PMID:
36516084
DOI:
10.1182/bloodadvances.2022008219
Journal:
Blood Advances
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record

Record Created: